Cidara Provides Corporate Update and Reports Third Quarter 2018 Financial Results
November 08, 2018 17:23 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Therapeutics to Present at Two Upcoming Investor Conferences
September 24, 2018 16:05 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...
Cidara Therapeutics Announces Offering of Common Stock and Warrants
May 21, 2018 07:30 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has...
Cidara Announces Appointment of Chrysa Mineo as Independent Director
March 01, 2018 16:05 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the...
Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
February 27, 2018 16:32 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Provides Corporate Update and Reports Third Quarter 2017 Financial Results
November 08, 2017 16:01 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...